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1. Introduction 
Amyloidosis is induced by deposition of amyloid proteins in various organs. Both systemic 
and localized type amyloidosis present with a variety of skin manifestations. Based on 
biochemical and immunological aspects, amyloid proteins are subdivided into several 
subtypes from different origins. Amyloid fibrils in primary and multiple myeloma-
associated systemic amyloidosis are composed of immunoglobulin protein AL (light chain), 
whereas in secondary systemic amyloidosis, they are composed of a non-immunoglobulin 
protein (amyloid AA). In primary localized cutaneous amyloidosis, amyloid materials are 
derived from cytokeratin; however, in nodular primary cutaneous amyloidosis, amyloid is 
AL type. Dialysis-related amyloidosis is composed of β2-microglobulin. 
So far, there are several reviews of skin features associated with amyloidosis [1-3]. 
Cutaneous amyloidosis is characterized by deposition of amyloid in the skin, which is seen 
in association with systemic amyloidosis and also restricted to the skin. In case of 
association with systemic amyloidosis, skin lesions are important as one of the extra-
hematologic manifestations, because cutaneous lesions may occasionally be the initial 
presentation of systemic amyloidosis. Representative lesions include petechiae, purpura, 
ecchymoses, and eyelid translucent papulonodular lesions. By contrast, amyloidosis limited 
to the skin is called primary localized cutaneous amyloidosis, which is clinically classified 
into more common macular, papular, and the rare nodular form. Also, reports of cases 
showing peculiar forms of cutaneous amyloidosis are seen, depending on the different 
races. Additionally, amyloid deposition is secondarily seen in association with skin tumors, 
such as basal cell carcinoma, Bowen’s disease, and other benign tumors. In this review, both 
primary and secondary skin lesions associated with systemic as well as cutaneous 
amyloidosis are discussed, making a focus on mucocutaneous manifestations. 
2. Amyloid materials 
Various subtypes of cutaneous amyloid are distinguished. Amyloid deposits are verified by 
several specific stains such as PAS, thioflavine T fluorescence, Congo red, and Dylon (Fig. 
1). Light microscopy reveals amorphous materials extracellularly. Investigation by electron 
microscopy shows fibrillar materials (Fig. 2).  
3. Systemic amyloidosis 
Primary systemic amyloidosis (AL amyloidosis) is caused by plasma cell dyscrasia, and 
develops in 10-20% of patients with multiple myeloma. Various organs are affected such as 
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Fig. 1. Massive amyloid deposition with melanophages is seen in the papillary dermis in the 
lesional skin of lichen amyloidosis (Congo red staining). Hyperkeratosis of the overlying 
epidermis is also seen 
 
 
Fig. 2. Electron microscopy shows fibrillar materials consistent with amyloid (A) and normal 
collagen (C) 
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renal, cardiac, neuronal, gastrointestinal, hepatic, and splenic involvement. Skin 
manifestation is seen in approximately 30-40% of patients. Purpura, petechiae, and 
ecchymoses are induced in the skin as well as mucous membranes. Eyelid purpura is 
frequently seen (Fig. 3), and purpura are also seen elsewhere in the body. Purpura is caused 
by minor trauma, slight stimuli, or even spontaneously. Amyloid deposition is seen around 
the blood vessels, which causes capillary fragility. As periorbital lesions, translucent nodules, 
xanthomatous plaques, waxy yellowish hemorrhagic lesions are seen (Fig. 4, 5). 
 
 
Fig. 3. Purpuric plaques around the bilateral eyelids 
 
Fig. 4. Periorbital xanthomatous plaques and purpura 
Other rare forms of cutaneous amyloidosis associated with systemic amyloidosis include 
subcutaneous nodules, whitish nodules, bullous lesions, and refractory ulcers [4, 5]. 
Amyloid deposition is also occasionally seen in the tongue and oral mucosa. Macroglossia is 
the representative sign (Fig. 6). Nail involvement is due to amyloid deposition in the nail 
matrix, and can be an initial manifestation of systemic amyloidosis [6]. Nail lesions present 
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Fig. 5. Waxy, yellowish hemorrhagic lesions 
 
 
Fig. 6. Macroglossia in a patient with systemic amyloidosis 
with dystrophy, thinning, whitening, banding, striations, brittleness, onycholysis, fragility, 
and even anonychia (Fig. 7). Alopecia may develop when amyloid deposition occurs on the 
hair matrix. Scleroderma-like manifestations are rarely seen, especially on the fingers, in 
patients with primary systemic amyloidosis [7-9]. Skin biopsy is important for the diagnosis, 
because amyloid deposition can be detected even in the skin of normal appearance. Blind 
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aspiration biopsies from the abdominal subcutaneous fat tissues or the rectal submucosa are 
sometimes useful for the definitive diagnosis for systemic amyloidosis. 
 
 
Fig. 7. Fingernails of a patient with systemic amyloidosis showing longitudinal ridging and 
splitting 
4. Localized amyloidosis 
Primary localized cutaneous amyloidosis (PLCA) is defined by deposition of amyloid in 
previously normal skin with no evidence of deposits in internal organs, and classified into 
more common macular, papular, and the rare nodular form. PLCA may be induced by 
chronic stimuli or minor trauma [10]. 
Lichen amyloidosis is frequently seen on the dorsal aspect of the lower legs and forearms, 
which is characterized by pruritic, firm, hyperkeratotic, reddish-brown papules or nodules 
(Fig. 8). Main component of amyloid in lichen amyloidosis is considered to be cytokeratin, 
suggesting that amyloid deposits may be derived from degenerated epithelial cells. 
Macular amyloidosis is predominantly localized on the upper back, and characterized by 
dark pigmented macules with a rippled pattern of pigmentation (Fig. 9). In severe cases, 
macular amyloidosis involves all over the back (Fig. 10). Lichen amyloidosis and macular 
amyloidosis are occasionally seen in a single patient, and is known as biphasic forms. 
Unique features of macular amyloidosis are rarely seen on the upper back or exterior 
aspects of upper extremities. Lesions are pigmented, discrete spotty papules and not 
presented hyperkeratotic papules like lichen amyloidosis (Fig. 11). Those lesions are 
induced by prolonged scraching or rubbing with various objects such as bath sponges, 
brushes, towels, plant sticks and leaves, which resulted in keratinocyte degenereation. The 
same clinical entity includes friction amyloidosis, friction melanosis, and towel melanosis 
[11]. Friction amyloidosis is induced by long-term use of a nylon towel or scrub brush over 
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Fig. 8. Lichen amyloidosis on the lower leg 
 
 
Fig. 9. Macular amyloidosis on the upper back 
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Fig. 10. Widespread primary cutaneous localized amyloidosis (macular form) 
 
 
Fig. 11. Pigmented papular form of macular amyloidosis on the upper back (insert: higher 
magnification) 
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the bony regions such as the arms, forearms, clavicle, scapula, and neck [12, 13]. Amyloid 
deposits in the skin may be derived from degenerated epithelial keratinocytes [14], possibly 
through filamentous degeneration or apoptosis [15]. Histological investigation by amyloid 
stain show deposition of amorphous materials in the papillary dermis. Amyloid is usually 
detected unassociated with hair follicles, but rarely recognized around the follicles (Fig. 12). 
Nodular amyloidosis presents with a single or multiple nodules on the face, trunk and 
extremities [16, 17], which sometimes develop following trauma (Fig. 13). Also, periorbital 
small, waxy nodules are multiply seen. In the nodular type, amyloid is originated from AL 
protein by local plasma cells, and modified β2-microglobulin is also shown to be a 
component of amyloid fibrils [18]. Apart from other types, amyloid materials are situated up 
to in the deep dermis. Plasma cell infiltration is prominent within or peripheral areas of the 
amyloid materials (Fig. 14). Although patients with nodular amyloidosis may develop 
systemic amyloidosis after long-term follow-up, recent papers indicate that the ratio is lower 
than previously reported [16]. In the series of 16 cases of nodular amyloidosis, 2 patients had 
Sjögren’s syndrome, 2 had diabetes mellitus, and 3 had liver disease. In particular, 
association with Sjögren’s syndrome is remarkable [19]. 
PLCA usually is unassociated with systemic disorders; however, a few cases of HCV-related 
amyloidosis have been reported [20, 21], one of which was biphasic PLCA [20]. Nodular 
lesions showing the surface atrophy are described as amyloidosis cutis nodularis 
atrophicans. 
Additionally, other unusual variants of PLCA have been reported depending on genetic, 
racial, and environmental factors. Those include poikiloderma-like appearance, reticular 
 
 
Fig. 12. Amyloid deposition around the hair follicle in the papillary dermis in the lesional 
skin of macular amyloidosis (Congo red) 
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Fig. 13. Nodular amyloidosis on the chin 
 
 
Fig. 14. Plasma cell infiltration in the lesional skin of nodular amyloidosis 
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form, hypopigmented, widespread diffuse pigmentation, incontinentia pigmenti-like 
pattern, homogenous pigmented patched, and amyloidosis cutis dyschromia [22-30]. Also, 
eczematous lesions [31, 32] and bullous lesions mimicking bullous pemphigoid [33] have 
been reported. Rare sites include ear, nose, and cheek [34-38]. Anosacral cutaneous 
amyloidosis is frequently seen in Asian elderly people, and hyperkeratotic, pigmented 
plaques are located on the bilateral outer area of the anus (Fig. 15). 
 
 
Fig. 15. Anosacral amyloidosis 
Therapeutic modalities for cutaneous amyloidosis remain a challenge, although topical 
application of corticosteroids and dimethylsulfoxide (DMSO), phototherapy, and laser 
treatment are selected. 
5. Secondary amyloidosis associated with various disorders 
An association of cutaneous amyloidosis with various disorders (i.e. inflammatory 
disorders, autoimmune disorders, and tumors) has been reported. Amyloid deposition is 
occasionally seen associated with chronic inflammation, and secondary cutaneous amyloid 
deposition is sometimes seen in patients with atopic dermatitis [39]. Chronic stimuli by 
frequent scratching may play a triggering role in amyloid production from keratinocytes. 
Additionally, secondary amyloid deposition associated with inflammatory disorders, such 
as psoriasis [40] or disseminated superficial porokeratosis [41] have been reported. 
Connective tissue diseases or collagen vascular diseases have been rarely seen, such as 
systemic sclerosis, lupus erythematosus, Sjögren’s syndrome, rheumatoid arthritis, 
dermatomyositis, Behchet’s disease, sclerodermatomyositis, generalized morphea-like 
scleroderma, sarcoidosis, and so on [42-47]. Association of PLCA with various autoimmune 
disorders suggests that underlying immune-mediated factors may be implicated [47].  
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Secondary amyloid deposition is occasionally associated with both benign and malignant 
skin tumors such as melanocytic naevi, seborrheic keratosis, calcifying epithelioma, 
dermatofibroma, solar keratosis, Bowen’s disease, basal cell carcinoma, trichoepithelioma, 
and so on [48-56]. Although an epidermal origin of amyloid in secondary cutaneous 
amyloidosis, particularly in association with skin tumors of epithelial cell origin, is 
suggested in several conditions, degenerating naevus cells may contribute to the amyloid 
production [55]. A previous report showed amyloid deposition in Bowen’s disease treated 
with radiotherapy [53]. It is suggested that any insult to the skin leading to degenerative cell 
changes could result in amyloid deposition.  
6. Dialysis-related amyloidosis 
In dialysis-related amyloidosis, skin manifestations often present with cutaneous or 
subcutaneous nodules [57, 58]. Bilateral subcutaneous masses are seen on the buttocks (Fig. 
16), which are sometimes painful on sitting. Extensive deposition of β2-microglobulin 
amyloid is seen in the dermis to subcutis, occasionally associated with local calcification. 
 
 
Fig. 16. Dialysis-related amyloidosis on the buttocks 
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